high SYNTAX Score? I Sheiban Division of Cardiology Interventional Card. University of Turin Turin / Italy

Similar documents
COMMENT DEFINIR UN PLURITRONCULAIRE. Didier Carrié CHU Toulouse Rangueil

The SYNTAX-LE MANS Study

EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017

Important LM bifurcation studies update

Benefit of Performing PCI Based on FFR

The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study

Michael Mack, M.D. Baylor Healthcare System Heart Hospital Baylor Plano Dallas, TX

PCI vs. CABG From BARI to Syntax, Is The Game Over?

FFR in Multivessel Disease

Rationale for Percutaneous Revascularization ESC 2011

Fractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center

Left Main Intervention: Where are we in 2015?

R&M Solutions

Mise à Jour sur le traitement du Pluritronculaire Philippe Généreux, MD

Controversies in Coronary Revascularization. Atlanta CCU April 15, 2016

Michael Mack, M.D. Baylor Healthcare System Heart Hospital Baylor Plano Dallas, TX

Incidence and Treatment for LM In-Stent

Surgery Grand Rounds

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

Left Main Intervention: Will it become standard of care?

Implications of the New ESC/EACTS Guidelines for Myocardial Revascularization in 2011

PTCA 1979: : I

Unprotected Left Main Stenting: Patient Selection and Recent Experience. Alaide Chieffo. S. Raffaele Hospital, Milan, Italy

VCU Pauley Heart Center: A 2009 US News Top 50 Heart and Heart Surgery Hospital

Management of High-Risk Coronary Artery Disease

Are Asian Patients Different? - Updates Of Biomatrix Experience In Regional Settings: BEACON II (3 Yr F up) &

FAME STUDY: 2-year Follow-Up & CLINICAL SUBGROUP ANALYSIS

Controversies in Cardiac Surgery

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

IVUS vs FFR Debate: IVUS-Guided PCI

Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program

Unprotected LM intervention

Fractional Flow Reserve: Review of the latest data

Most Patients with Elective Left Main Disease. Farrel Hellig

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France

Left Main and Bifurcation Summit I. Lessons from European LM Studies

FFR-Guided PCI. 4 th Imaging and Physiology Summit October 29 th, 2010 Seoul, Korea. Stanford

Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome

Upgrade of Recommendation

FFR-guided Jailed Side Branch Intervention

Abbott Vascular. PROTOCOL EXCEL Clinical Trial

When should we indisputably perform CABG? Quand faut-il indiscutablement opérer? Dr Hakim BENAMER

Drug Eluting Stents: Bifurcation and Left Main Approach

ANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC. Seoul, Korea: April The problem is exaggerated: Data from Real World Registries

COMPARE Trial Elvin Kedhi Maasstad Ziekenhuis Rotterdam The Netherlands

Integrated Use of IVUS and FFR for LM Stenting

DES In-stent Restenosis

PCI for Long Coronary Lesion

Coronary interventions

Intracoronary Imaging For Complex PCI A Pichard, L Satler, Ron Waksman, I Ben-Dor, W Suddath, N Bernardo, D Harrington.

Assessing Myocardium at Risk: Applying SYNTAX

PCI for In-Stent Restenosis. CardioVascular Research Foundation

PCI for LMCA lesions A Review of latest guidelines and relevant evidence

Fractional Flow Reserve and the Results of the FAME Study

What do the guidelines say?

Percutaneous Intervention of Unprotected Left Main Disease

Fractional Flow Reserve. A physiological approach to guide complex interventions

Diabetic Patients: Current Evidence of Revascularization

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

Final Clinical and Angiographic Results From a Nationwide Registry of FIREBIRD Sirolimus- Eluting Stent: Firebird In China (FIC) Registry (PI R. Gao)

Application of Appropriate Use Criteria in Clinical Care of CAD. Peter K. Smith, MD Professor and Chief Thoracic Surgery Duke University 4/29/2012

Technical considerations in the Treatment of Left Main Lesions Ioannis Iakovou, MD, PhD

Coronary stenting: the appropriate use of FFR

Side Branch Occlusion

PCI for Chronic Total Occlusions

LM stenting - Cypher

RESTENOSIS Facing up to the problem

Cost-Effectiveness of Fractional Flow Reserve

Left Main PCI. Integrated Use of IVUS and FFR. Seung-Jung Park, MD, PhD

Left Main Disease: what is left to surgery? Prof. Jacques Monségu CardioVascular Institute Grenoble, France

Final Kissing Ballooning Returns? The analysis of COBIS II registry

Prognostic Value of Gated Myocardial Perfusion SPECT

FRACTIONAL FLOW RESERVE: STANDARD OF CARE

SYNTAX score before decision making! Corrado Tamburino, MD, PhD

FRACTIONAL FLOW RESERVE USE IN THE CATH LAB BECAUSE ANGIOGRAPHY ALONE IS NOT ENOUGH!!!!!!!!

Unprotected left main coronary stenting with a second generation drug-eluting stent. One-year clinical follow-up of the LeMaX pilot study.

Count Down to COMBAT

Le# Main Interven-on: When Is It Appropriate. Femi Philip, MD Assistant Professor Of Medicine UC Davis

Management of cardiovascular disease - coronary interventions -

DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea.

Mid-term results from real-world REPARA registry. Felipe Hernandez, on behalf of the REPARA investigators

Better CABGs vs Better PCI Devices

PCIs on Intermediate Lesions NCDR Cath-PCI Registry

PCI for Left Anterior Descending Artery Ostial Stenosis

Perspective of LM stenting with Current registry and Randomized Clinical Data

Diagnostic, Technical and Medical

CARDIOLOGY SYMPOSIUM 2015 CAROLINA CARDIOLOGY CONSULTANTS OF GHS

CLINICAL CONSEQUENCES OF THE

FFR Incorporating & Expanding it s use in Clinical Practice

PROMUS Element Experience In AMC

Δημήτριος Αγγοσράς, FETCS

On-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery

FFR= Qs/Qn. Ohm s law R= P/Q Q=P/R

Ziyad Ghazzal MD, FACC, FSCAI Professor of Medicine Deputy Vice President/Dean Associate Dean for Clinical Affairs American University of Beirut

Clinical Considerations for CTO

Medical Rx vs PCI vs CABG

New Generation Drug- Eluting Stent in Korea

Chronic Total Occlusion: a case for coronary artery bypass grafting

Transcription:

What to do with patients with high SYNTAX Score? I Sheiban Division of Cardiology Interventional Card. University of Turin San Giovanni Battista Hospital Turin / Italy

Who are the patients with high SYNTAX Score Dominance Calcification Thrombus Bifurcation Number & location of lesions SYNTAX Score Left Main 3-vessel Total Occlusion Complex anatomy Multivessel disease Diffuse disease Tortuosity See Glossary for prescribing information outside the US

Patients in SYNTAX Randomized Controlled Trial Intent-to to-treat RCT: Enrolled N=1800 CABG n=897 vs PCI * n=903 RCT: 1 Year Follow-up N=1740 (96.7%) CABG n=849 vs PCI * n=891 RCT: 2 Year Follow-up N=1721 (95.6%) CABG n=836 vs PCI * n=885 * TAXUS Express

SYNTAX Score Anatomic ScoringFor Each Lesion Segment: Location Length Calcification Tortuosity Bifurcation Diffuse Disease Occlusion Thrombus SYNTAX Score = 18 SYNTAX Score = 41

SYNTAX Score : Low < 22 Intermediate : 23-32 High : > 33

MACCE to 2 Years by SYNTAX Score Tercile Low Scores (0-22) CABG (N=171) TAXUS (N=181) CABG PCI P value 40 3VD Death 5.5% 5.1% 0.85 Cumulative Event Rat te (%) 30 20 10 P=0.25 21.9% 16.5% CVA 1.9% 1.2% 0.57 MI 4.2% 3.9% 0.90 Death, CVA or 9.7% 8.4% 0.67 MI 0 0 12 24 Months Since Allocation Revasc. 7.6% 17.1% 0.01 Cumulative KM Event Rate ± 1.5 SE; log-rank P value Site-reported Data; ITT population

MACCE to 2 Years by SYNTAX Score Tercile Intermediate Scores (23-32) CABG (N=208) TAXUS (N=207) TAXUS CABG PCI P value 40 3VD Death 4.1% 6.4% 0.30 Cumulative Event Rat te (%) 30 20 10 P=0.0202 23.0% 13.7% CVA 3.1% 2.0% 0.50 MI 2.6% 7.4% 0.03 Death, CVA or 8.6% 11.7% 0.29 MI 0 0 12 24 Months Since Allocation Revasc. 73% 7.3% 16.1% 1% 0006 0.006 Cumulative KM Event Rate ± 1.5 SE; log-rank P value Site-reported Data; ITT population

MACCE to 2 Years by SYNTAX Score Tercile High Scores ( 33) 40 CABG (N=166) TAXUS (N=155) 3VD CABG PCI P value Death 2.5% 8.5% 0.02 Cumulative Event Rat te (%) 30 20 10 P=0.003 26.8% 13.3% CVA 1.9% 2.1% 0.95 MI 1.9% 7.2% 0.02 Death, CVA or 6.3% 13.7% 0.03 MI 0 0 12 24 Months Since Allocation Revasc. 77% 7.7% 19.3% 0002 0.002 Cumulative KM Event Rate ± 1.5 SE; log-rank P value Site-reported data; ITT population

Patients (%) 20 15 10 5 0 Stent Number and Length Higher in the SYNTAX Trial 48% of patients received 5 stents Multivessel disease: 96.2%* 3-vessel disease: 90.8% Avg. stents per patient: 4.6 ± 2.3 Avg. stented length: 86.1 mm Max # 14 stents! 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 *3VD+LM/3VD+LM/2VD+LM/1VD Total Number of Stents Implanted per Patient

Linear Increase in MACCE by Number of Stentsin the SYNTAX Trial 0,30 1.5 Stents Typical Real World Average 4.6 Stents SYNTAX Average 17.8% Avg. in pts with 5-8+ stents in SYNTAX 19.6% 12m MACC CE in TA AXUS Ar rm 025 0,25 0,20 0,15 0,10 005 0,05 1stent 5.6% 12m MACCE Probability 12m MACCE Rate 0,00 1 2 3 4 5 6 7 8 8+ Number of Stents Implanted

Based on these data : I can conclude at this point my presentation : No discussion : CABG is preferd in patients with high SYNTAX SCORE But what about CABG?

Durability of Saphenous Vein Grafts 100 90 80 70 60 50 40 30 20 10 0 7 Diseased 19 48 Occluded 25 77 1 year 5 years 10 years 40 Goldman S. J Am Coll Cardiol. 2004

Cumulative patency (<70% stenosis) by type of graft Khot UN et al. Cleveland Clinic, Circulation 2004;109:2086-91 B 5 i f l h 40% By 5 years, vein graft patency was less than 40%. It was even worse for radial artery conduits and not much better for RIMAs!

PCI vs CABG The Good Face of PCI Mini-invasivity invasivity Effectiveness of DES The Bad Face of PCI? Multiple stenting ( full metal Jacket ) Stent thrombosis Syntax Score

SYNTAX Trial : Not all MV disease are equal. MULTIVESSEL DISEASE Variables Anatomy Disease Extension MVD Disease Severity Patient comorbidity

SYNTAX Score Reproducibility in diffuse MV disease : Operator 1 : SYNTAX SCORE = 33 Operator 2 : SYNTAX SCORE = 22

SYNTAX Score Reproducibility Inter-observer Number of lesions 0.62 Bifurcation lesions 0.36 Ostial lesions 0.66 CTO lesions 0.91 Intra-observer : SYNTAx score grouped in deciles : 0.54 SYNTAX Score grouped in terciles: 0.51 Garg S. et al, CCI 2010 ; 75:946-952

SYNTAX Score Reproducibility Garg S. et al, CCI 2010 ; 75:946-952

SYNTAX Score & Functional Evaluation is not mandatory for every patient : SYNTAX Score = 12 PCI is an excellent option

SYNTAX Score & Functional Evaluation is not mandatory for every patient : SYNTAX Score = 38, CABG is 1 option

Diffuse Multivessel disease in diabetic patient Syntax Score = 47 Is this patient a good surgical candidate?

Multivessel Disease : SYNTAX Score : 37

At least 2 stents : At Least 2 stents At Least 2 stents Intention to treat : a total of at least 6 stents.. CABG should be the I choice

Multivessel Disease : Total Syntax Score = 37 Syntax Score= 14 Syntax Score= 23 CABG or PCI? CABG is preferd, but as alternative :

Good Option : PCI on prox LAD and prox LCX ( with 2 stents ) No intervntion on RCA

What is Is it the optimal approach? SYNTAX SCORE = 35 LAD treated with 7 stents! Certainly is not the optimal...

FFR-guided PCI? Stenting only lesions with FFR < 0.80

The use of Functional Evaluation ( FFR ) during MVD PCI reduce the number of stents t and MACE.. SYNTAX Score = 38

Angio-driven procedure = 6 stents Angio driven procedure 6 stents CABG is preferd. As altervnative :

FFR-driven procedure = 3 stents Functional SYNTAX Score = 17

Multivessel Disease SYNTAX SCORE = 46 Severe aortic calcification Severe coronary calcification CABG? Or PCI LCX and med LAD?

FFR=0.72 FFR =0.68 Distal CTO : Would PCI at this level change patient s outcome? Functional SYNTAX = 23 Functional SYNTAX = 23 FFR Guided PCI is a good option.

Functional SYNTAX Score 497 patients, FFR-guided arm of FAME Study 2-3 vessel disease Angio g Syntax Score : Conventional fashion Functional ( FFR) Syntax Score : counting only the lesions with FFR < 0.80 Angio SYNTAX Functional ( FFR ) SYNTAX FFR reclassifies > 30%! Fearon WF et al, TCT-MD 2011

Funtctional SYNTAX Score desciminates Risk of Death/MI and Risk of Total MACE Death / MI Total MACE Fearon WF et al, TCT-MD 2011

Is it safe to defer treatment?

DEFER Study : 5-year Follow-up o ( Death / MI )

FFR-Guided PCI in Multivessel Disease 137 patients, non-randomized Wongpraparut et al, AJC 2005; 96:877-884

FAME study: Event-free Survival absolute difference in MACE-free survival FFR-guided 30 days 2.9% 90 days 38% 180 days Angio-guided 3.8% 4.9% 360 days 5.3%

FAME study: 2-year Event-free Survival

Stent length / Number of stent & restenosis stent thrombosis

Stent Length is Independent Predictor of Restenosis. Lee CW et al. Am J Cardiol 2006;97:506-511 % 20 15 P<0.001 17,4 10 8,5 5 5,3 0 < 20 20 ~ 40 > 40 mm

Multivariate Predictors of In-Segment Restenosis after SES RESEARCH Registry OR 95% CI p ISR 4.16 1.63-11.01 <0.01 Ostial lesion 4.84 1.81-12.07 <0.01 DM 2.63 1.14-6.31 0.02 Stent length 1.42 1.21-1.68 <0.01 Ref diameter 046 0.46 024087 0.24-0.87 003 0.03 LAD 0.30 0.10-0.69 <0.01 Lemos PA et al. Circulation 2004;109:1366-1370

Full Metal Jacket. Ielasi, Colombo et al. Ital J Inv Cardiol 2009; 3 Suppl: 111 658 full metal jacket lesions ( 60mm) in 617 patients. 33% DM, 33 had prior PCI, 33% CTO. 39 months mean follow up (2 yr in 91% pts). Mortality 7.3% MI during follow up: 3.5% TLR: 23.4% Stent thrombosis (Def or Probable): 2.6% (10/17 while on DAP).

DES Thrombosis and Length DES Thrombosis and Length R. Moreno et al. JACC 2005;45:954-9

When long / multiple stents have restenosis. re-pci difficult and uneffective treatment and CABG is not anymore an option

PRACTICAL CONCLUSIONS MVD with high SYNTAX Score CABG should be considered as first choice paricularly when : Patients who Attempt need PCI - as if: ITT - > 4-5 stents > 1 clinically CABG relevant contraindicated CTO Patient/family and cardiac Inexperienced operator (<1000 PCI) surgeon agree on PCI Other cardiac surgery indications MVD With CABG High favored, SYNTAX but PCI Score is a without good alternative any of above unfavorable especially features: if FFR-guided A functional SYNTAX Score ( FFR ) can be more appropriate to select patients with MVD for a more appropriate treatment option

THANK YOU FOR YOUR ATTENTION